Join Nostr
2026-08-19 18:53:45 UTC
in reply to

Nonilex on Nostr: The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had ...

The trial enrolled 1,137 high-risk patients with stage 2b to 4 #melanoma that had been surgically removed.

Volunteers were randomized to receive up to 9 doses of #Keytruda plus ⁠the personalized #vaccine or Keytruda alone for about one year. The companies said no new safety signals have emerged in the trial. Previous studies showed the most common side effects were fatigue, pain at the injection site & chills [better than dying!].

#PublicHealth #health #science #medicine #MedicalBreakthrough